Safety and efficacy of immune checkpoint inhibitors in advanced cancer patients with autoimmune disease: A meta-analysis

• Главные авторы: Qi Cai (Автор), Geng-wei Huo (Автор), Fu-yi Zhu (Автор), Ping Yue (Автор), Dong-qi Yuan (Автор), Peng Chen (Автор)
• Формат: ‌
• Опубликовано: Taylor & Francis Group, 2022-12-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Cancer patients with autoimmune disease (AID) are usually excluded from clinical trials involving immune checkpoint inhibitors (ICIs). The available electronic databases were systematically searched from inception until July 3, 2022. We recorded the incidence of immune-related adverse events (irAEs)...